WHAT WE DO

Bring Digital Innovation to Healthcare

Light The Way to A Healthy Life

In order to serve more patients globally, we tear down obstacles, move ahead, and use digital tools to drive clinical practices by concentrating on core issues such motor dysfunction, cognitive impairment, psychological illnesses, and behavioral challenges.

By meeting the clinical requirements of patients and physicians, we adapt artificial intelligence, virtual reality, and other digital technologies into cutting-edge therapeutic tools, and keep enhancing healthcare experience.

We bring innovaion to resolve the brain health challenges to current healthcare system.

Media Resources

Neuton Health’s VR therapy for acrophobia receives NMPA class II approval

March 14, 2022 By Zhang Mengying

Neuton Health Co. Ltd.’s virtual reality (VR)-based therapy for acrophobia has been given class II medical device approval from China’s NMPA. The VR therapy, known as Specific Fear Rehabilitation Training Software, was co-developed with the Shanghai Mental Health Center. The digital therapy company said it is the first VR device of its kind for a specific phobia approved in the world.

Management of Parkinson's disease patients after DBS by remote programming

Journal of Neurology volume 268, pages1295–1303 (2021)

Abstract

Introduction: Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson's disease (PD). On time follow-up and timely programing of symptoms are important measures to maintain the effectiveness of DBS. Due to the highly contagious nature of 2019-nCoV, patients were quarantined. With the help of Internet technologies, we continued to provide motor and non-motor symptom assessment and remote programming services for postsurgical PD-DBS patients during this extraordinary period.

Methods: A retrospective analysis was performed on postsurgical PD-DBS patients who could not come to our hospital for programming due to the impact of the 2019-nCoV. The differences between the pre- and post-programming groups were analyzed. We designed a 5-level Likert rating scale to evaluate the effects and convenience of the remote programming and Internet self-evaluation procedures.

Results: Of the 36 patients engaged in the remote programming, 32 patients met the inclusion criteria. Four of the 32 patients set initiated stimulation parameters, and the other 28 patients had significant improvement in UPDRS-III. Nearly all the 28 patients were satisfied with the effect of the remote programming. Most of the patients were willing to use remote programming again.

Conclusion: Remote programming based on the online evaluation of patient's symptoms can help improve motor symptoms of postsurgical DBS patients with PD during the quarantine period caused by 2019-nCoV.

Keywords: 2019-nCoV; Deep brain stimulation (DBS); Parkinson’s disease (PD); Remote programming; Telemedicine.